Piramal Pharma Solutions opens API plant at Aurora, Canada
13 July 2022 | News
The new plant, built as part of a CAD $30 million capital investment in the Aurora site, features more than 10000 square feet of new manufacturing space
Image credit: www.prnewswire.com
Piramal Pharma Solutions officially inaugurated a new active pharmaceutical ingredient (API) plant at the company's site in Aurora, Ontario.
The new plant, built as part of a CAD $30 million capital investment in the Aurora site, features more than 10000 square feet of new manufacturing space and includes two new reactor suites with additional filtration and drying capabilities. It will support ongoing customer demand for Piramal Pharma Solutions' expertise in APIs and enhances and expands the company's ability to produce clinical to commercial scale APIs, including highly potent APIs requiring an Occupational Exposure Limit (OEL) of 1mcg/m3.
